Literature DB >> 24175754

The future of tic disorder treatment.

Shannon M Bennett1, Alex E Keller, John T Walkup.   

Abstract

Competing theories on the etiology and treatment of chronic tic disorders and Tourette syndrome have long made the search for efficacious intervention more challenging for patients and families seeking to reduce functional impairment related to tic symptoms. These symptoms were historically posited to be either psychological in origin, leading to the long tradition of psychoanalytic psychotherapy for tics, or biological in nature, particularly since the advent of successful treatments using neuroleptic medications. Current thinking about the phenomenology of tic disorders comes from growing empirical evidence as well as advances in neuroscience and genetics research and reveals a biological vulnerability that is exacerbated by physiological arousal related to environmental or interpersonal stress. This manuscript summarizes the evolution of this knowledge base and describes current best-practice recommendations for patients, families, and clinicians.
© 2013 New York Academy of Sciences.

Entities:  

Keywords:  Tourette syndrome; behavior therapy; psychopharmacology; tic disorders

Mesh:

Substances:

Year:  2013        PMID: 24175754     DOI: 10.1111/nyas.12296

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

Review 1.  The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Authors:  Cathy L Budman
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

2.  The Efficacy and Tolerability of the Clonidine Transdermal Patch in the Treatment for Children with Tic Disorders: A Prospective, Open, Single-Group, Self-Controlled Study.

Authors:  Pan-Pan Song; Li Jiang; Xiu-Juan Li; Si-Qi Hong; Shuang-Zi Li; Yue Hu
Journal:  Front Neurol       Date:  2017-02-23       Impact factor: 4.003

3.  Tourette Syndrome: a general pediatrician's 35-year experience at a single center with follow-up in adulthood.

Authors:  Debra L Byler; Lisa Chan; Erik Lehman; Ashley D Brown; Syeda Ahmad; Cheston Berlin
Journal:  Clin Pediatr (Phila)       Date:  2014-09-07       Impact factor: 1.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.